Go to industries


Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
deals closed in Healthcare
Explore all our industry-related deals
Go to deals
Enterprises ImportFab Inc. has been acquired by Labomar S.p.A
Healthcare | Private Equity

Enterprises ImportFab Inc. has been acquired by Labomar S.p.A

Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.

Learn more
“I am very happy with the deal we closed and I don’t think I could have expected a better outcome. The company I have built will continue to grow and my employees are protected. The Oaklins team did an amazing job. Their professionalism and dedication were beyond my expectations. I would highly recommend them to anyone looking for a financial advisor you can trust.”

Sylvain Renzi

Founder, Enterprises ImportFab, Inc.

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=CA&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Reshaping industries: M&A highlights and strategic vision

QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.

Learn more

Talk to our local advisors

Sebastien Alarie

Montreal, Canada
Oaklins E. Canada

Meet our global industry specialists

Antoine Lemaire

Paris, France
Oaklins France

Robert Boersma

Amsterdam, Netherlands
Oaklins Netherlands

Dino Theodorou

Johannesburg, South Africa
Oaklins Grindrod

Stuart Goodman

London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital